Blog

TIME Recognises Drug Design for Global Health (dd4gh) Among 2026’s Best Inventions

The Drug Design for Global Health (dd4gh) project, developed by deepmirror in partnership with Medicines for Malaria Venture (MMV), has been named on TIME’s Best Inventions of 2026 list in the Social Impact category.

Screening 1 Billion Molecules Against Cancer Targets in Just a Few Hours: Tes Pharma’s Journey with deepmirror™

deepmirror™ enabled Tes Pharma to screen 1 billion molecules in just a few hours, unlocking novel chemotypes against one of the toughest target classes in drug discovery.

Co-creating an innovative AI platform to advance global health research

Researchers from around the world collaborate with MMV and deepmirror to adapt machine-learning platform to accelerate drug discovery.

Collaborative Drug Discovery and deepmirror Announce Collaboration for Humanitarian and Commercial Drug Discovery

Partnership between Collaborative Drug Discovery and deepmirror announced.

Evaluating Boltz-2 on Real Drug Targets: Does it work?

Evaluating Boltz-2 on Real Drug Targets: Does it work?

Boltz-2 released on deepmirror

Using Boltz-2 for fast co-folding and affinity prediction

Obtaining actionable solubility predictions with deepmirror

New collaboration with the Sanders Tri-Institutional Therapeutics Discovery Institute

Medicines for Malaria Venture and deepmirror join forces for global health

The Drug Design for Global Health platform aims to accelerate global health security by supporting scientists in LMICs

Breaking Barriers in Protein Structure Prediction: A Secure Solution for Challenging Targets

deepmirror, in collaboration with Google Cloud, enabled Curie.Bio to run advanced protein structure models to tackle challenging, undrugged targets.

Top Drug Discovery Software Solutions to Watch in 2025

Overview of top drug discovery software solutions to watch in 2025.

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.